Air pollution increases death risk in people with certain diseases

May 22, 2006

SAN DIEGO--People with diabetes, heart failure, chronic obstructive pulmonary disease and inflammatory diseases such as rheumatoid arthritis are at increased risk of death when they are exposed to particulate air pollution, or soot, for one or more years, according to a study to be presented at the American Thoracic Society International Conference on May 22nd.

The study looked at hospital discharges for people with these four types of diseases living in 34 cities between 1985 and 1999. The researchers compared this information with 12-month averages of PM10, a type of particulate matter air pollution that includes particles with a diameter of 10 micrometers or less than 0.0004 inches or one-seventh the width of a human hair.

The study found that for an increase of 10 micrograms/per cubic meter of PM10 over two years, the risk of dying was increased by: "The study significantly strengthens evidence that breathing in particulate matter is associated with dying sooner," said researcher Joel Schwartz, Ph.D., Professor of Environmental Epidemiology at the Harvard School of Public Health in Boston.

"While previous studies have found that long-term exposure to air pollution is associated with increased risk of death, we looked at risk of death in the first three years after patients were discharged from the hospital, and saw that the risk increased in the first couple of years. That means if we can lower air pollution levels, people will start living longer right away--we don't have to wait many years to see health improvements. That wasn't clear from previous air pollution studies."

Technology that can reduce particulate matter levels already exists, Dr. Schwartz noted. "For instance, we know how to put scrubbers on coal-burning power plants, which are a major source of particulate matter. There is no safe level of particulate air pollution, so we need to get the levels as low as reasonably possible."

While previous studies have linked exposure to PM10 to harmful effects on breathing and respiratory systems, damage to lung tissue, cancer, and premature death, this is the first study to follow people with specific diseases to determine their risk of death in response to particle exposure, Dr. Schwartz said.

He noted an important difference between this new study and past air pollution studies. "Past studies have compared average air pollution conditions in one city to other cities, and you need to worry about potential confounders, or other factors that could affect the differences between the cities," he said. "In this study, we looked at air pollution and deaths within each city--we didn't compare across cities, so we didn't need to worry about confounding factors."

The study helps validate the findings of previous studies that have shown that long-term exposure to air pollution is associated with shortened survival in the general population, said Dr. Schwartz, a co-author of the Six Cities Study, which evaluated the effects of pollution on adults in the 1970s and 1980s. The results of that study found a strong, positive correlation between levels of air pollution and mortality. The study led to a revision of existing air quality standards by the U.S. Environmental Protection Agency. An eight-year follow up study found an association between people living longer and cities reducing the amount of fine particulate matter in their air. That study was published in the March 15, 2006 issue of the American Thoracic Society journal, The American Journal of Respiratory and Critical Care Medicine.
-end-


American Thoracic Society

Related Heart Failure Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Machining the heart: New predictor for helping to beat chronic heart failure
Researchers from Kanazawa University have used machine learning to predict which classes of chronic heart failure patients are most likely to experience heart failure death, and which are most likely to develop an arrhythmic death or sudden cardiac death.

Heart attacks, heart failure, stroke: COVID-19's dangerous cardiovascular complications
A new guide from emergency medicine doctors details the potentially deadly cardiovascular complications COVID-19 can cause.

Autoimmunity-associated heart dilation tied to heart-failure risk in type 1 diabetes
In people with type 1 diabetes without known cardiovascular disease, the presence of autoantibodies against heart muscle proteins was associated with cardiac magnetic resonance (CMR) imaging evidence of increased volume of the left ventricle (the heart's main pumping chamber), increased muscle mass, and reduced pumping function (ejection fraction), features that are associated with higher risk of failure in the general population

Transcendental Meditation prevents abnormal enlargement of the heart, reduces chronic heart failure
A randomized controlled study recently published in the Hypertension issue of Ethnicity & Disease found the Transcendental Meditation (TM) technique helps prevent abnormal enlargement of the heart compared to health education (HE) controls.

Beta blocker use identified as hospitalization risk factor in 'stiff heart' heart failure
A new study links the use of beta-blockers to heart failure hospitalizations among those with the common 'stiff heart' heart failure subtype.

Type 2 diabetes may affect heart structure and increase complications and death among heart failure patients of Asian ethnicity
The combination of heart failure and Type 2 diabetes can lead to structural changes in the heart, poorer quality of life and increased risk of death, according to a multi-country study in Asia.

Preventive drug therapy may increase right-sided heart failure risk in patients who receive heart devices
Patients treated preemptively with drugs to reduce the risk of right-sided heart failure after heart device implantation may experience the opposite effect and develop heart failure and post-operative bleeding more often than patients not receiving the drugs.

How the enzyme lipoxygenase drives heart failure after heart attacks
Heart failure after a heart attack is a global epidemic leading to heart failure pathology.

Novel heart pump shows superior outcomes in advanced heart failure
Severely ill patients with advanced heart failure who received a novel heart pump -- the HeartMate 3 left ventricular assist device (LVAD) -- suffered significantly fewer strokes, pump-related blood clots and bleeding episodes after two years, compared with similar patients who received an older, more established pump, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

Read More: Heart Failure News and Heart Failure Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.